Literature DB >> 15728930

Inhaled nitric oxide treatment of patients with pulmonary tuberculosis evidenced by positive sputum smears.

Richard Long1, Richard Jones, James Talbot, Irvin Mayers, James Barrie, Michael Hoskinson, Bruce Light.   

Abstract

Endogenous nitric oxide (NO) has antimycobacterial properties. We tested the hypothesis that exogenous (inhaled) NO can be safely delivered and can accelerate airway disinfection for pulmonary tuberculosis patients treated with standard therapy. Exogenous NO administered at 80 ppm for 72 h can be safely delivered but does not accelerate airway disinfection.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15728930      PMCID： PMC549277          DOI： 10.1128/AAC.49.3.1209-1212.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

Authors:  Henry M Blumberg; William J Burman; Richard E Chaisson; Charles L Daley; Sue C Etkind; Lloyd N Friedman; Paula Fujiwara; Malgosia Grzemska; Philip C Hopewell; Michael D Iseman; Robert M Jasmer; Venkatarama Koppaka; Richard I Menzies; Richard J O'Brien; Randall R Reves; Lee B Reichman; Patricia M Simone; Jeffrey R Starke; Andrew A Vernon
Journal:  Am J Respir Crit Care Med       Date:  2003-02-15       Impact factor: 21.405

2.  Mycobacteriocidal action of exogenous nitric oxide.

Authors:  R Long; B Light; J A Talbot
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

3.  Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.

Authors: 
Journal:  N Engl J Med       Date:  1997-02-27       Impact factor: 91.245

Review 4.  What is the role of nitric oxide in murine and human host defense against tuberculosis?Current knowledge.

Authors:  E D Chan; J Chan; N W Schluger
Journal:  Am J Respir Cell Mol Biol       Date:  2001-11       Impact factor: 6.914

5.  The early bactericidal activity of drugs in patients with pulmonary tuberculosis.

Authors:  A Jindani; V R Aber; E A Edwards; D A Mitchison
Journal:  Am Rev Respir Dis       Date:  1980-06

6.  Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutol.

Authors:  J M Dickinson; D A Mitchison
Journal:  Tubercle       Date:  1976-12

7.  Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity.

Authors:  Gilla Kaplan; Frank A Post; Andre L Moreira; Helen Wainwright; Barry N Kreiswirth; Melike Tanverdi; Barun Mathema; Srinivas V Ramaswamy; Gabi Walther; Lafras M Steyn; Clifton E Barry; Linda-Gail Bekker
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

8.  Effects of guanidino and uremic compounds on nitric oxide pathways.

Authors:  R J MacAllister; G S Whitley; P Vallance
Journal:  Kidney Int       Date:  1994-03       Impact factor: 10.612

9.  Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment.

Authors:  Richard Long; Karen Bochar; Sylvia Chomyc; James Talbot; James Barrie; Dennis Kunimoto; Peter Tilley
Journal:  Infect Control Hosp Epidemiol       Date:  2003-11       Impact factor: 3.254

10.  Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis.

Authors:  J Chan; K Tanaka; D Carroll; J Flynn; B R Bloom
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441
View more
  13 in total

Review 1.  Immunoregulatory and antimicrobial effects of nitrogen oxides.

Authors:  Joan B Mannick
Journal:  Proc Am Thorac Soc       Date:  2006-04

2.  Feedback-controlled photolytic gas phase nitric oxide delivery from S-nitrosothiol-doped silicone rubber films.

Authors:  Gergely Lautner; Orsolya Lautner-Csorba; Blake Stringer; Mark E Meyerhoff; Steven P Schwendeman
Journal:  J Control Release       Date:  2019-11-25       Impact factor: 9.776

Review 3.  The emerging role of gasotransmitters in the pathogenesis of tuberculosis.

Authors:  Krishna C Chinta; Vikram Saini; Joel N Glasgow; James H Mazorodze; Md Aejazur Rahman; Darshan Reddy; Jack R Lancaster; Adrie J C Steyn
Journal:  Nitric Oxide       Date:  2016-07-04       Impact factor: 4.427

4.  Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: association with disease severity and delayed mycobacterial clearance with treatment.

Authors:  Anna P Ralph; Tsin W Yeo; Cheryl M Salome; Govert Waramori; Gysje J Pontororing; Enny Kenangalem; Emiliana Tjitra; Richard Lumb; Graeme P Maguire; Ric N Price; Mark D Chatfield; Paul M Kelly; Nicholas M Anstey
Journal:  J Infect Dis       Date:  2013-06-03       Impact factor: 5.226

5.  Tuberculosis: new aspects of an old disease.

Authors:  Luisa Jordao; Otilia V Vieira
Journal:  Int J Cell Biol       Date:  2011-06-21

6.  Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial.

Authors:  Michael Hawkes; Robert O Opoka; Sophie Namasopo; Christopher Miller; Kevin E Thorpe; James V Lavery; Andrea L Conroy; W Conrad Liles; Chandy C John; Kevin C Kain
Journal:  Trials       Date:  2011-07-13       Impact factor: 2.279

Review 7.  Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis.

Authors:  Hamidreza Jamaati; Esmaeil Mortaz; Zeinab Pajouhi; Gert Folkerts; Mehrnaz Movassaghi; Milad Moloudizargari; Ian M Adcock; Johan Garssen
Journal:  Front Microbiol       Date:  2017-10-12       Impact factor: 5.640

8.  Design, Synthesis and Biological Evaluation of Nitrate Derivatives of Sauropunol A and B as Potent Vasodilatory Agents.

Authors:  Lu Lu; Xuemin Rao; Rigang Cong; Chenxi Zhang; Zhimei Wang; Jinyi Xu; Genzoh Tanabe; Osamu Muraoka; Xiaoming Wu; Weijia Xie
Journal:  Molecules       Date:  2019-02-06       Impact factor: 4.411

9.  Gaseous nitric oxide reduces influenza infectivity in vitro.

Authors:  Gilly Regev-Shoshani; Selvarani Vimalanathan; Bevin McMullin; Jeremy Road; Yossef Av-Gay; Chris Miller
Journal:  Nitric Oxide       Date:  2013-04-02       Impact factor: 4.427

10.  Portable Nitric Oxide (NO) Generator Based on Electrochemical Reduction of Nitrite for Potential Applications in Inhaled NO Therapy and Cardiopulmonary Bypass Surgery.

Authors:  Yu Qin; Joanna Zajda; Elizabeth J Brisbois; Hang Ren; John M Toomasian; Terry C Major; Alvaro Rojas-Pena; Benjamin Carr; Thomas Johnson; Jonathan W Haft; Robert H Bartlett; Andrew P Hunt; Nicolai Lehnert; Mark E Meyerhoff
Journal:  Mol Pharm       Date:  2017-10-25       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.